| | Author | Age, | Stage | Histology | Immuno-phenotype | Initial treatment | Survival, mo |
| 1934 | Fresnais | 73 | IE | LS | NA | O | DOD, 5 | 1936 | Slotkin | 36 | IE | LS | NA | O | DOD, 1 | 1949 | Hector | 64 | IE | RES | NA | O | DOD, 62 | 1954 | Wetterwald | 49 | IIE | LB | NA | O | DOD, 1 | 1957 | Pelot | 21 | IE | RS | NA | O, RT | DOD, 12 | 1970 | Bologna | 42 | IE | LRS | NA | O, RT | DOD, 6 | 1970 | Gotou | 57 | IE | RS | NA | O, RT | NA | 1972 | Iwata | 30 | IIE | LS | NA | O, CT | DOD, 3 | 1972 | Katou | 75 | III | RS | NA | O, CT | DOD, 3 | 1980 | Karapandov | 57 | IE | CB/CC | NA | O, RT | NA | 1982 | Guena | 46 | IE | CB/CC | NA | NA | NA | 1982 | Satou | 49 | IE | Burkitt | B | O, CT | NA | 1986 | Hautzer | 54 | IE | CBD | NA | O | DOD, 7 | 1986 | Hanada | 74 | IE | DLC | NA | O | DOD, 5 | 1989 | Zwanger-Mendelson | 20 | IV | Burkitt | B | O | DOD, 1 | 1989 | Ooyama | 66 | IIE | DLC | NA | O, CT | NA | 1990 | D’Abrosca | 89 | IE | CBD | NA | NA | DOD, NA | 1990 | Nishimura | 47 | IIE | DLC | NA | O, CT | NA | 1994 | Möller | 48 | IV | CBD | B | NA | DOD, 8 | 1994 | Kawanishi | 66 | IE | DMC | NA | O, CT, RT | NA | 1994 | Asanuma | 78 | IE | DLC | NA | CT | NA | 1994 | Oonishi | 76 | IE | DMC | NA | O | NA | 1996 | Lands | 57 | IE | DLC | B | O | DOD, 26 | 1997 | Umehara | 78 | IE | DLC | NA | O | NA | 1998 | Ichiyanagi | 77 | IIE | DLC | B | O, CT | DOD, 10 | 2001 | Okabe | 76 | IE | DMC | B | O | DOD, 40 | 2007 | Kawano | 57 | IIE | DLBCL | B | O, CT | NA | 2008 | Nakano | 54 | IVA | DLBCL | B | O, CT | DOD, 5 | 2009 | Natsuizaka | 75 | IE | DLBCL | B | O, CT | NA | 2009 | Almeida | 71 | IE | DLBCL | B | O, CT | NA | 2009 | Suzuki | 74 | IIIA | DLBCL | B | O, CT | DOD, 13 | 2009 | Asano | 71 | IE | DLBCL | B | O, CT | NA | 2011 | Our case | 62 | IVB | DLBCL | B | O, CT, RT, IT | NA |
|
|
O, orchiectomy; CT, chemotherapy; RT, radiotherapy; IT, intrathecal chemotherapy; CBD, centroblastic diffuse; CB/CC, centroblastic/centrocytic; LB, lymphoblastic; LS, lymphosarcoma; RS, reticulosarcoma; LRS, lymphoreticulosarcoma; RES, reticuloendotheliosarcoma; DLC, diffuse large cell; DMC, diffuse medium cell; DLBCL, diffuse large B-cell lymphoma; mo, months; NA, not available; DOD, died of disease.
|